- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03543943
Achilles Tendon Elongation and Gait Pattern After Rupture.
Achilles Tendon Elongation and Gait Pattern After Rupture: A Three Armed Randomized Controlled Trial Comparing an Individualized Treatment Algorithm vs. Operative or Non-operative Treatment.
The objective of this study is to determine if Achilles tendon elongation and gait pattern differ between patients treated using an individualized treatment algorithm and patients treated as usual (two control groups; patients treated operatively and non-operatively).
The individualized treatment algorithm is based on ultrasonographic status of tendon overlap and Copenhagen Achilles Length Measure (1). Patients are allocated for operative treatment if there the tendon overlap is less than 25 % or the tendon is elongated with 7% or more compared to the healthy, contralateral achilles tendon.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hvidovre
-
Copenhagen, Hvidovre, Denmark, DK-2650
- Department of Physiotherapy and Orthopedical surgery, Copenhagen University Hospital, Amager-Hvidovre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Appointment in the Outpatients Department within 4 days of injury.
- Total Achilles tendon rupture.
- Initial treatment with split cast with the ankle in maximal plantar flexion must be started within 24 hours of injury.
- The patient must be expected to be able to attend rehabilitation and postexamination.
- The patient must be able to speak and understand Danish.
- The patient must be able to give informed consent.
Exclusion Criteria:
- Rupture of the Achilles tendon either at the insertion on the calcaneus or at musculotendinous junction of the triceps surae.
- Previous rupture of the Achilles tendon in any of the two legs.
- Treated with fluoroquinolones or corticosteroids within the last 6 months.
- In medical treatment of diabetes.
- Suffers from rheumatic disease.
- Other conditions prior to the injury resulting in reduced function of any of the two legs.
- Contra-indication for surgery: severe arthrosclerosis with no palpable pulse in the foot, broken skin in the Achilles region of the injured leg.
- Inability to lie in prone position on the operating table.
- Terminal illness or severe medical illness: American Society of Anaesthesiologists physical status classification score higher than or equal to 3.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Individualized treatment
The ruptured achilles tendon is examined by ultrasonography.
If the overlap of the tendon ends is less than 25 % or the tendon is elongated 7 % or more the patient receives conventional open operative treatment.
The tendon is sutured with double fiberwire size 2 a.m.
Kessler under prophylactic Dicloxacillin 2 g and in local anesthesia or alternatively popliteal or spinal block.
The injured leg is placed in a circulated below the knee cast after surgery.
The ankle is held at maximal plantar flexion.
Weight bearing is not allowed.
After 3 weeks the cast is removed and the injured leg is transferred to a functional brace with 3 heel wedges.
The patient will follow standard functional rehabilitation and the follow-up evaluations.
|
The most proximal border of the calcaneus and the most distal point of the musculotendinous junction of the medial gastrocnemius muscle is identified and marked on the skin.
These two points on the un-injured leg defines the original length of the total Achilles tendon [1].
The difference in length between the injure and the un-injured leg determines elongation for the ruptured Achilles tendon.
The relative elongation of the ruptured tendon together with overlap of the tendon ends on the cross-sectional area determines the treatment for the patients receiving individualized treatment: 1) patients with 0-6% elongation of the tendon and a minimum of 25% tendon are treated non-operatively 2) patients with 7% elongation or more or less than 25% tendon overlap are treated operatively.
|
ACTIVE_COMPARATOR: Control group 1
For the patients allocated to non-operative treatment the injured leg is placed in a circulated below the knee cast from the time of the first appointment in the Outpatients Department.
The ankle is held at maximal, unforced plantar flexion.
Weight bearing is not allowed and the patient should walk with the aid of crutches.
After 3 weeks from initiated treatment in the Emergency Department the cast is removed in the Outpatients Department and the injured leg is transferred to a functional brace (Walker boot) with 3 heel wedges promoting 20 degrees plantar flexion over the ankle.
The patient will follow standard functional rehabilitation and the follow-up evaluations.
|
Circulated cast below the knee in maximal, unforced plantar flexion over the ankel.
|
ACTIVE_COMPARATOR: Control group 2
The tendon is sutured with double fiberwire size 2 a.m.
Kessler under prophylactic Dicloxacillin 2 g and in local anesthesia or alternatively popliteal or spinal block.
The injured leg is placed in a circulated below the knee cast from the time of the first appointment in the Outpatients Department.
The ankle is held at maximal, unforced plantar flexion.
Weight bearing is not allowed and the patient should walk with the aid of crutches.
After 3 weeks from initiated treatment in the Emergency Department the cast is removed in the Outpatients Department and the injured leg is transferred to a functional brace (Walker boot) with 3 heel wedges promoting 20 degrees plantar flexion over the ankle.
The patient will follow standard functional rehabilitation and the follow-up evaluations.
|
Open surgery with suture of the ruptured achilles tendon prior to circulated cast below the knee in maximal, unforced plantar flexion over the ankel.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Three-Dimensional Gait Analysis: Ankle peak power during push-off.
Time Frame: 12 months after started treatment.
|
Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers.
The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory.
Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.
|
12 months after started treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Copenhagen Achilles Length Measure
Time Frame: 6 and 12 months after started treatment.
|
The examination of both the total and the free part of the achilles tendon of both the injured and un-injured leg is performed.
The total length of the tendon is defined under the description of the intervention.
The free part of the achilles tendon is defined as the distance between the proximal border of calcaneus and the musculotendinous junction of the soleus muscle and the achilles tendon.
The method will be used both diagnostically for the individualized treatment and as a secondary endpoint.
|
6 and 12 months after started treatment.
|
Three-Dimensional Gait Analysis: Ankle peak power during push-off
Time Frame: 6 months after started treatment.
|
Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers.
The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory.
Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.
|
6 months after started treatment.
|
Three-Dimensional Gait Analysis: Maximal dorsiflexion in the stance phase.
Time Frame: 6 and 12 months after started treatment.
|
Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers.
The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory.
Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.
|
6 and 12 months after started treatment.
|
Three-Dimensional Gait Analysis: stiffness of the plantar flexor musculo-tendinous complex during dorsiflexion.
Time Frame: 6 and 12 months after started treatment.
|
Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers.
The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory.
Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.
|
6 and 12 months after started treatment.
|
Three-Dimensional Gait Analysis: time of heel-lift
Time Frame: 6 and 12 months after started treatment.
|
Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers.
The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory.
Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.
|
6 and 12 months after started treatment.
|
Three-Dimensional Gait Analysis: jumping up and down
Time Frame: 6 and 12 months after started treatment.
|
Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers.
The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory.
Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.
|
6 and 12 months after started treatment.
|
Balance measurement
Time Frame: 6 and 12 months after started treatment.
|
The postural sway with patient standing on a force plate in the gait laboratory.
|
6 and 12 months after started treatment.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Achilles HVH RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Achilles Tendon Rupture
-
Aristotle University Of ThessalonikiGeneral Hospital of Naoussa; Private Orthopedics Practice P. SymeonidisEnrolling by invitationAchilles Tendon Rupture | Achilles Tendon Injury | Achilles Tendon SurgeryGreece
-
Henry Ford Health SystemRecruitingAchilles Tendon Rupture | Achilles Tendon SurgeryUnited States
-
Aarhus University HospitalEnrolling by invitationAchilles Tendon Rupture | Achilles Tendon InjuryDenmark
-
Chinese University of Hong KongNot yet recruitingAchilles Tendinopathy | Achilles Tendon RuptureHong Kong
-
Penn State UniversityRecruiting
-
Bispebjerg HospitalCompletedAchilles Tendon RuptureDenmark
-
Region SkaneLund UniversityCompleted
-
Hvidovre University HospitalCompletedAchilles Tendon RuptureDenmark
-
Peking University Third HospitalCompletedAchilles Tendon RuptureChina
-
University of OxfordNational Institute for Health Research, United KingdomCompletedAchilles Tendon RuptureUnited Kingdom
Clinical Trials on Non-operative treatment
-
Luzerner KantonsspitalArthrex GmbHNot yet recruiting
-
Unity Health TorontoUniversity of British Columbia; McGill University Health Centre/Research Institute... and other collaboratorsCompletedClavicle Fracture | FracturesCanada
-
Tampere University HospitalRegionshospitalet Viborg, Skive; Central Finland Hospital District; Satakunta...RecruitingDistal Radius FractureDenmark, Finland, Sweden
-
University of Missouri-ColumbiaWithdrawnClavicle FracturesUnited States
-
Lawson Health Research InstituteCompleted
-
Ostfold Hospital TrustRecruitingAnkle Fracture, Trimalleolar | Ankle Fracture, BimalleolarNorway
-
University of OuluActive, not recruitingLateral Malleolus FractureFinland
-
Helsinki University Central HospitalCompletedFracture | ClavicleFinland
-
Medical University of ViennaCompletedOsteoporotic Fractures